Start-up aims to open the door to an entirely new approach to immunotherapy

Pathios Therapeutics raises $25M in first close of Series B financing to advance first-in-class immunotherapy approach into clinic

23-Apr-2024 - Pathios Therapeutics Limited, a biotech company focused on the development of first-in-class therapies for cancer, announced that the company has raised USD $25 million in the first close of a Series B financing. The financing consists of a new strategic investment from Bristol Myers Squibb, as ...

Labguru joins Titian Software in Battery Ventures Life-Science Platform

Labguru will combine forces with Titian Software to create a global tier-1 lab-management and sample-management platform

19-Apr-2024 - Battery Ventures, a global, technology-focused investment firm, announced the acquisition of Labguru (BioData Inc.), the life-science laboratory-data platform, from Holtzbrinck Digital. Terms were not disclosed. Labguru provides a comprehensive laboratory data-management hub for planning and ...

Scientists identify rare gene variants which confer up to 6-fold increase in risk of obesity

Genetic variants reveal new biological mechanism regulating appetite control

10-Apr-2024 - A study led by Medical Research Council (MRC) researchers has identified genetic variants in two genes that have some of the largest impacts on obesity risk discovered to date. The discovery of rare variants in the genes BSN and APBA1 are some of the first obesity-related genes identified for ...

CryoLogyx Completes £500k Seed Funding Round

Investment to support commercialization of pre-plated, assay-ready, cryopreserved cells for drug discovery, diagnostic and cell therapy applications

27-Mar-2024 - CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, announced the close of its oversubscribed seed funding round. The £500k GBP investment came from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN), which includes ...

Tiny wireless light bulbs for biomedical applications

The combination of OLEDs and acoustic antennas creates light source that can be used for minimally invasive treatment methods

11-Mar-2024 - A research team from the University of St. Andrews and the University of Cologne has developed a new wireless light source that might one day make it possible to 'illuminate' the human body from the inside. Such light sources could enable novel, minimally invasive means to treat and better ...

Groundbreaking study: 'Mini-organs' created from amniotic fluid for the first time

Stem cells collected in late pregnancy herald advances in prenatal medicine

07-Mar-2024 - A pioneering approach, developed by researchers at UCL and Great Ormond Street Hospital (GOSH), means human development can be observed in late pregnancy for the first time, raising the possibility of monitoring and treating congenital conditions before birth. The study, published in Nature ...

PharmaKure announces collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions

04-Mar-2024 - PharmaKure announces a new epigenetics collaboration with Sheffield Hallam University. This partnership will focus on ‘gene-based environmental biomarkers’, known as epigenetic markers, for calculating risk scores for Alzheimer’s diseases. Together withALZmetrixTM, PharmaKure’s blood-based ...

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

“MIP Discovery’s synthetic affinity reagents hold huge potential to overcome bottlenecks in cell and gene therapy development and production”

28-Feb-2024 - MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate the development and production of cell and gene therapies, announced it has closed a £7 million GBP (~$9 million USD) Series A financing round, led by Mercia Ventures. Existing investor Calculus ...

Using metabolomics for assessing safety of chemicals may reduce the use of lab rats

"We hope that learnings from this research will be included in new guidance for the chemical industry to allow commercial laboratories to provide these services widely"

26-Feb-2024 - Scientists have discovered a more robust way of grouping chemicals and using read-across for toxicological data to meet regulatory requirements, which could greatly reduce animal testing. The safety of chemicals is taken incredibly seriously by regulators and as such industry must meet certain ...

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

14-Feb-2024 - BioNTech SE and Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T programs towards commercialization, pending regulatory ...